Interní Med. 2007; 9(3): 118-122

Contrast media - induced nephropathy

MUDr. Darja Krusová
II. interní klinika FN u sv. Anny LF MU, Brno

Contrast media – induced nephropathy (CMIN) is an iatrogenic disorder, resulting from exposure to contrast media. With the growing number of diagnostic and interventional radiologic procedures in recent years, the prevalence of this order can be expected to increase.This article briefly tackles the currently known patophysiological mechanisms that lead to CMIN. There are the number of patient-related risk factors which increase the probability of its occurance after radiologic procedures, as the presence of diabetes mellitus, preexisting renal impairment and hypertension. In addition the development of contrast nephropathy is much more increased in patients with risk medication. The preventive measurs are mentioned in the article. Its very important to realise the possibility of occurence of CMIN and to prevent it also by the modification of influenceable risk factors, for example by the elimination of risk medication.

Keywords: Key words: nephropathy, contrast media – induced nephropathy, aethiopathophysiology, risk factors, N-acetylcystein, ACE inhibitors.

Published: April 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krusová D. Contrast media - induced nephropathy. Interní Med. 2007;9(3):118-122.
Download citation

References

  1. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. New England Journal of Medicine 2003; 348 (6): 491-499. Go to original source... Go to PubMed...
  2. Brendan J, Barrett MB, Parfey PS. Preventing nephropathy induced by contrast medium. N Engl J Med 2006; 354 (4): 379-386. Go to original source... Go to PubMed...
  3. Cavusoglu E, Chhabra S, Marmur JD, et al. The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Minerva Cardioangiol 2004; 52 (5): 419-432. Go to PubMed...
  4. Gami AS, Garovic VD: Contrast nephropathy after coronary angiography. Mayo Clin Proc 2004; 79 (2): 211-219. Go to original source... Go to PubMed...
  5. Goldenberg I, Matetzky S. Nephropathy induced by contrast media: Pathogenesis, risk factors and preventive strategies. Canadian Medical Association Journal 2005; 172 (11): 1461-1471. Go to original source... Go to PubMed...
  6. Harwood SM, Yaqoob MM, Allen DA. Caspase and calpain function in cell death: Bridging the gap between apoptosis and necrosis. Annals of Clinical Biochemistry 2005; 42: 415-431. Go to original source... Go to PubMed...
  7. Chertow GM. Prevention of radiocontrast nephropathy: Back to basics. Journal of the American Medical Association 2004; 291 (19): 2376-2377. Go to original source... Go to PubMed...
  8. Idée JM, Lancelot E, Pines E, et al. Prophylaxis of iodinated contrast media-induced nephropathy: a pharmacological point of view. Invest Radiol 2004; 39 (3): 155-170. Go to original source... Go to PubMed...
  9. Johnson RJ, Feehalby J. Comprehensive clinical nephrology. London: 2003; 13-26: 215-216.
  10. Kandzari DE, Rebeiz AG, Wang A, et al. Contrast nephropathy: an evidence-based approach to prevention. Am J Cardiovasc Drugs 2003; 3 (6): 395-405. Go to original source... Go to PubMed...
  11. Katholi RE, Woods WT jr., Taylor GJ et al. Oxygen free radicals and contrast nephropathy. Am J Kidney Dis 1998; 32: 64-71. Go to original source... Go to PubMed...
  12. Liang M, Knox FG. Production and functional roles of nitric oxide in the proximal tubule. Am. J. Physiol. 2000; 278 (5): 47. Go to original source... Go to PubMed...
  13. Mehran R, Nikolsky E. Contrast-induced nephropathy: Definition, epidemiology, and patients at risk Kidney Int 2006; 69: S11-S15. Go to original source... Go to PubMed...
  14. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial, JAMA 2004; 291 (19): 2328-2334. Go to original source... Go to PubMed...
  15. Oudemans-van Straaten HM. Contrast nephropathy, pathophysiology and prevention. Int J Artif Organs 2004; 27 (12): 1054-1065. Go to original source... Go to PubMed...
  16. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention, Circulation, 2002; 105 (19): 2259-2264. Go to original source... Go to PubMed...
  17. Schück O, Tesař V, Teplan V. Klinická nefrologie. 1. vyd., Medprint, 1995: 266.
  18. Soma VR, Cavusoglu E, Vidhun R, et al. Contrast-associated nephropathy. Heart Dis 2002; 4 (6): 372-379. Go to original source... Go to PubMed...
  19. Štípek S, et al. Antioxidanty a volné radikály ve zdraví a nemoci. 1. vyd. Praha: Grada publishing 2000: 77-92.
  20. The Royal Australian and New Zealand College of Radiologists: Guidelines for metformin hydrochloride and intravascular contrast, 2006; http://www.ranzcr.edu.au/collegegroups/reference/EBM/mhicm_guidelines.cfm.
  21. Welch WJ, Tojo AB, Wilcox CS. Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am J of Physiol Renal Physiol 2000; 278: F769-776. Go to original source... Go to PubMed...
  22. Zager RA, Johnson AC, Hanson SY. Radiographic contrast media-induced tubular injury: Evaluation of oxidant stress and plasma membrane integrity. Kid Int 2003; 64: 128-139. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.